Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity

Li-Jun Ma1, Bridgette A Corsa, Jun Zhou

  • 1Department of Pathology, Vanderbilt Univ. Medical Center, Nashville, TN 37232-2561, USA. Lijun.ma@vanderbilt.edu

Insights

Obesity accelerates kidney injury by increasing inflammation and shifting macrophage balance towards a proinflammatory state. Blocking the angiotensin type 1 receptor reduces these harmful effects in obese mice.

Area of Science:

  • Nephrology
  • Metabolic Diseases
  • Immunology

Background:

  • Obesity is a risk factor for chronic kidney disease (CKD), but mechanisms are unclear.
  • The renin-angiotensin system plays a role in both obesity and CKD.
  • Angiotensin type 1 (AT(1)) receptor subtypes (AT(1a) and AT(1b)) are key components.

Purpose of the Study:

  • Investigate the role of the AT(1a) receptor in high-fat diet (HFD)-induced obesity and kidney injury.
  • Determine the impact of AT(1) receptor blockade on obesity-related renal inflammation and macrophage polarization.

Main Methods:

  • Used wild-type (WT) and AT(1a) knockout (AT1aKO) mice fed a HFD for 24 weeks.
  • Assessed metabolic parameters, body composition, and kidney histology.
  • Analyzed kidney and adipose tissue macrophage infiltration and M1/M2 polarization markers.
  • Administered an AT(1) receptor blocker to obese WT mice.

Main Results:

  • HFD induced obesity, insulin resistance, and kidney injury (mesangial expansion, tubular vacuolization) in WT mice.
  • AT1aKO mice had altered body fat and cholesterol but similar weight gain and kidney injury compared to obese WT mice.
  • Both obese groups showed increased kidney macrophage infiltration and M1 markers; AT1aKO mice had heightened abnormalities and increased AT(1b) expression.
  • AT(1) receptor blockade reduced renal macrophage infiltration, M1 markers, and promoted M2 markers in obese WT mice.

Conclusions:

  • Obesity exacerbates kidney injury through increased inflammation in adipose and kidney tissues.
  • A proinflammatory shift in macrophage M1/M2 balance contributes to obesity-related kidney damage.
  • Targeting the AT(1) receptor may mitigate obesity-induced kidney injury by modulating inflammation.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...